Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kerr Group was a U.S.-based packaging manufacturer focused on specialty plastic closures, prescription packaging components, and related containers used in pharmaceutical, healthcare, food, and beverage markets. The company was particularly known for child-resistant and tamper-evident closure technologies and for working with pharmaceutical customers on packaging designs that supported regulatory and FDA-related requirements. Historically, Kerr evolved from a glass container business into a broader plastics and packaging company serving both healthcare and consumer end markets. It was acquired by Calera Capital in August 1997 and was later sold to Ball Corporation, so it is best characterized as a commercial packaging business rather than a drug developer or biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kerr Group.